晨岭资本 CDG Capital

Established in 2016, CDG Capital is an international investment management company which is excelling at exploring extraordinary portfolio companies through its expertise in Healthcare, High-End Manufacturing and TMT sectors with private equity investments. Equipped with impressive investment performance and highly skilled professionals, CDG Capital is appointed as the sole advisor of China Reform Conson Soochow Overseas Fund I L.P. and CRF Envirotech Fund L.P. with AUM of US$650 million. Relying on its abundant investment experience and industry resources, CDG Capital has invested in a number of outstanding companies, including Innovent Biologics (1801.HK), Akeso, Inc. (9926.HK), Tigermed (3347.HK), Farasis Energy (688567.SH) ,Antengene（6996.HK), RemeGen(9995.HK), etc.